RATING

RECOMMENDATION

Strong Sell

  • ROFR Required
  • Available in Depository:

  • NSDL

  • CDSL

  • Available for Investment:

  • Primary

  • Secondary

RATING

RECOMMENDATION

Strong Sell

Business Type

Traditional Business

RATING

RECOMMENDATION

Strong Sell

Business Type

Traditional Business

Mitsui acquires 5% in Arch Pharma

23 September, 2010 • economictimes

Arch Pharma buys Benzochem for Rs 100 cr

09 June, 2008 • economictimes

Arch Pharmalabs looking at takeovers in Europe

26 February, 2008 • economictimes

  • Disclaimer

Investment disclaimer

Investment in pre IPO-equity is subject to market risk. The investor should take an informed decision before investing in any company. Our research report must be used for informational purposes only. Planify will not be responsible for any gain/loss on your investment.

Planify disclaimer

An investment made on the Planify platform is made through pooled investments that acquire shares of private companies and are not a direct investment in these companies.

Transaction disclaimer

Planify facilitates the smooth execution of the transaction. If in case, Planify is not able to provide or supply the requisite agreed inventory, it will return the transaction amount in the same account through which the funds are received.